Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

258 Views

Poster Session: Antimicrobial Novel Agents

1719 - In Vitro Activity of Ceftazidime-avibactam and Comparator Agents against Enterobacterales and Pseudomonas aeruginosa Collected from Patients with Bloodstream Infections as Part of the ATLAS Global Surveillance Program, 2017-2020

Saturday, October 22, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

The ePoster content is available to users who are logged in.<br><br>Please click the login button at the top right corner and then come back here to use this button.

Presenting Author(s)

Mark Estabrook, PhD

Laboratory Manager, Molecular Microbiology
IHMA
Schaumburg, Illinois, United States

Co-Author(s)

GS

Gregory Stone, PhD

Director of Microbiology
Pfizer, Inc.
Groton, Connecticut, United States
DS

Daniel F. Sahm, PhD

VP Global Microbiology Services & Chief Scientific Officer
IHMA
Schaumburg, Illinois, United States